180 related articles for article (PubMed ID: 22835954)
1. Synergic effect of photodynamic therapy using talaporfin sodium with conventional anticancer chemotherapy for the treatment of bile duct carcinoma.
Nonaka Y; Nanashima A; Nonaka T; Uehara M; Isomoto H; Abo T; Nagayasu T
J Surg Res; 2013 May; 181(2):234-41. PubMed ID: 22835954
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic Therapy Using Novel Glucose-conjugated Chlorin Increases Apoptosis of Cholangiocellular Carcinoma in Comparison with Talaporfin Sodium.
Murakami G; Nanashima A; Nonaka T; Tominaga T; Wakata K; Sumida Y; Akashi H; Okazaki S; Kataoka H; Nagayasu T
Anticancer Res; 2016 Sep; 36(9):4493-501. PubMed ID: 27630287
[TBL] [Abstract][Full Text] [Related]
3. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma.
Nonaka T; Nanashima A; Nonaka M; Uehara M; Isomoto H; Nonaka Y; Nagayasu T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):592-600. PubMed ID: 21360081
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma.
Wentrup R; Winkelmann N; Mitroshkin A; Prager M; Voderholzer W; Schachschal G; Jürgensen C; Büning C
Gut Liver; 2016 May; 10(3):470-5. PubMed ID: 26814610
[TBL] [Abstract][Full Text] [Related]
5. Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin
Nanashima A; Hiyoshi M; Imamura N; Hamada T; Nishida T; Kawakami H; Ban T; Kubota Y; Nakashima K; Yano K; Wada T; Takeno S; Kai M
Clin J Gastroenterol; 2020 Feb; 13(1):102-109. PubMed ID: 31222455
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial.
Nanashima A; Abo T; Nonaka T; Nonaka Y; Morisaki T; Uehara R; Ohnita K; Fukuda D; Murakami G; Tou K; Kunizaki M; Hidaka S; Tsuchiya T; Takeshita H; Nakao K; Nagayasu T
Anticancer Res; 2012 Nov; 32(11):4931-8. PubMed ID: 23155262
[TBL] [Abstract][Full Text] [Related]
7. Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
Tanaka M; Sasaki M; Suzuki T; Nishie H; Kataoka H
Biochem Biophys Res Commun; 2021 Feb; 539():1-7. PubMed ID: 33388624
[TBL] [Abstract][Full Text] [Related]
8. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Celli JP; Solban N; Liang A; Pereira SP; Hasan T
Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma.
Hong MJ; Cheon YK; Lee EJ; Lee TY; Shim CS
Gut Liver; 2014 May; 8(3):318-23. PubMed ID: 24827630
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma.
Larsen FO; Mellergaard AH; Hoegdall DT; Jensen LH
Acta Oncol; 2014 Oct; 53(10):1448-50. PubMed ID: 24930389
[No Abstract] [Full Text] [Related]
12. Gemcitabine-loaded DSPE-PEG-PheoA liposome as a photomediated immune modulator for cholangiocarcinoma treatment.
Kim DH; Im BN; Hwang HS; Na K
Biomaterials; 2018 Nov; 183():139-150. PubMed ID: 30170256
[TBL] [Abstract][Full Text] [Related]
13. Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
Fiteni F; Jary M; Monnien F; Nguyen T; Beohou E; Demarchi M; Dobi E; Fein F; Cleau D; Fratté S; Nerich V; Bonnetain F; Pivot X; Borg C; Kim S
BMC Gastroenterol; 2014 Aug; 14():143. PubMed ID: 25117717
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
Mita Y; Ajiki T; Kamigaki T; Okazaki T; Hori H; Horiuchi H; Hirata K; Fujita T; Fujimori T; Kuroda Y
Ann Surg Oncol; 2007 Apr; 14(4):1374-80. PubMed ID: 17235714
[TBL] [Abstract][Full Text] [Related]
15. INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.
Patt YZ; Murad W; Fekrazad MH; Baron AD; Bansal P; Boumber Y; Steinberg K; Lee SJ; Bedrick E; Du R; Lee FC
Cancer Med; 2017 Sep; 6(9):2042-2051. PubMed ID: 28801995
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.
Wagner AD; Buechner-Steudel P; Moehler M; Schmalenberg H; Behrens R; Fahlke J; Wein A; Behl S; Kuss O; Kleber G; Fleig WE
Br J Cancer; 2009 Dec; 101(11):1846-52. PubMed ID: 19904267
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells.
Tomioka Y; Kushibiki T; Awazu K
Photomed Laser Surg; 2010 Jun; 28(3):385-90. PubMed ID: 19860571
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Malka D; Cervera P; Foulon S; Trarbach T; de la Fouchardière C; Boucher E; Fartoux L; Faivre S; Blanc JF; Viret F; Assenat E; Seufferlein T; Herrmann T; Grenier J; Hammel P; Dollinger M; André T; Hahn P; Heinemann V; Rousseau V; Ducreux M; Pignon JP; Wendum D; Rosmorduc O; Greten TF;
Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
20. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.
Xie Q; Jia L; Liu YH; Wei CG
World J Gastroenterol; 2009 Feb; 15(6):737-41. PubMed ID: 19222100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
